Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Should You Buy?

Shares of Elekta AB (OTCMKTS:EKTAY) saw strong trading volume on Wednesday . 9,059 shares were traded during mid-day trading, an increase of 246% from the previous session’s volume of 2,617 shares.The stock last traded at $5.93 and had previously closed at $5.8425.

Elekta Price Performance

The company has a debt-to-equity ratio of 0.56, a current ratio of 0.95 and a quick ratio of 0.73. The firm has a market capitalization of $2.19 billion, a P/E ratio of -592.41 and a beta of 1.08. The firm’s 50 day simple moving average is $6.10 and its two-hundred day simple moving average is $5.74.

Elekta (OTCMKTS:EKTAY) last released its quarterly earnings data on Thursday, March 5th. The company reported $0.09 earnings per share (EPS) for the quarter. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.84%. The firm had revenue of $433.29 million for the quarter. As a group, analysts predict that Elekta AB will post 0.36 earnings per share for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.